3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
6
Urinary Bladder Neoplasms
2
Ovarian Neoplasms
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thymoma
1
Stomach Neoplasms
1
Pharyngeal Neoplasms
1
Oropharyngeal Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Gestational Trophoblastic Disease
1
Gastro-enteropancreatic neuroendocrine tumor
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Merkel Cell
1
Carcinoid Tumor
1
Breast Neoplasms
1
Interventions
Cisplatin
30
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
pembrolizumab
18
Specimen Handling
17
Cetuximab
16
Biopsy
13
Radiotherapy, Intensity-Modulated
12
Radiation
11
Paclitaxel
11
Carboplatin
11
Surveys and Questionnaires
10
Fluorouracil
10
Drug Therapy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Platinum
9
Surgical Procedures, Operative
8
X-Rays
7
Taxes
7
Celecoxib
7
Standard of Care
6
Sentinel Lymph Node Biopsy
6
Observation
5
Nivolumab
5
cemiplimab
4
Metformin
4
Interviews as Topic
4
Immunohistochemistry
4
Fluorodeoxyglucose F18
4
Docetaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
zimberelimab
×
Head & Neck
×
Clear all
NCT04892875
2023-11-30
PANTHEoN
Vanderbilt-Ingram Cancer Center
Phase 1
Withdrawn